{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T00:09:31Z","timestamp":1788307771836,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,5,17]],"date-time":"2011-05-17T00:00:00Z","timestamp":1305590400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1186\/1471-2458-11-329","type":"journal-article","created":{"date-parts":[[2011,6,11]],"date-time":"2011-06-11T06:24:56Z","timestamp":1307773496000},"source":"Crossref","is-referenced-by-count":22,"title":["Estimating background rates of Guillain-Barr\u00e9 Syndrome in Ontario in order to respond to safety concerns during pandemic H1N1\/09 immunization campaign"],"prefix":"10.1186","volume":"11","author":[{"given":"Shelley L","family":"Deeks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian H","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Anne","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Rosella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher O","family":"Mackie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camille","family":"Achonu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha S","family":"Crowcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,5,17]]},"reference":[{"key":"3096_CR1","unstructured":"Interim order respecting the sale of the vaccine for the novel influenza a H1N1 virus. [\n                    http:\/\/www.hc-sc.gc.ca\/dhp-mps\/prodpharma\/legislation\/interimorders-arretesurgence\/vaccin-eng.php\n                    \n                  ]"},{"key":"3096_CR2","volume-title":"Reported by Caroline Alphonso","author":"The Globe and Mail","year":"2009","unstructured":"The Globe and Mail: Health officials scramble to counter H1N1 myths; Safety and effectiveness of vaccine emphasized in effort to reassure skeptics as conspiracy theories go viral. Reported by Caroline Alphonso. 2009"},{"key":"3096_CR3","volume-title":"Reported by Meagan Fitzpatrick","author":"Ottawa Citizen","year":"2009","unstructured":"Ottawa Citizen: Nearly half of Canadians won't get H1N1 shot: poll; Health officials try to counter fear, confusion. Reported by Meagan Fitzpatrick. 2009"},{"key":"3096_CR4","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","volume":"110","author":"LB Schonberger","year":"1979","unstructured":"Schonberger LB, Bregman DJ, Sullivan-Bolyai JZ, Keenlyside RA, Ziegler DW, Retailliau HF, Eddins DL, Bryan JA: Guillain-Barr\u00e9 syndrome following vaccination in the National Influenza Immunization Program, United States, 1976-1977. Am J Epidemiol. 1979, 110: 105-123.","journal-title":"Am J Epidemiol"},{"key":"3096_CR5","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2165\/00002018-200932040-00005","volume":"32","author":"P Haber","year":"2009","unstructured":"Haber P, Sejvar J, Mikaeloff Y, DeStefano F: Vaccines and Guillain-Barr\u00e9 syndrome. Drug Saf. 2009, 32: 309-323. 10.2165\/00002018-200932040-00005.","journal-title":"Drug Saf"},{"key":"3096_CR6","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1136\/jnnp.2007.118810","volume":"79","author":"LJ Hauck","year":"2008","unstructured":"Hauck LJ, White C, Feasby TE, Zochodne DW, Svenson LW, Hill MD: Incidence of Guillain-Barr\u00e9 syndrome in Alberta, Canada: an administrative data study. J Neurol Neurosurg Psychiatry. 2008, 79: 318-320. 10.1136\/jnnp.2007.118810.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3096_CR7","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1001\/archinte.166.20.2217","volume":"166","author":"DN Juurlink","year":"2006","unstructured":"Juurlink DN, Stukel TA, Kwong J, Kopp A, McGeer A, Upshur RE, Manuel DG, Moineddin R, Wilson K: Guillain-Barr\u00e9 syndrome after influenza vaccination in adults: a population-based study. Arch Intern Med. 2006, 166: 2217-2221. 10.1001\/archinte.166.20.2217.","journal-title":"Arch Intern Med"},{"key":"3096_CR8","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1086\/594124","volume":"48","author":"V Sivadon-Tardy","year":"2009","unstructured":"Sivadon-Tardy V, Orlikowski D, Porcher R, Sharshar T, Durand MC, Enouf V, Rozenberg F, Caudie C, Annane D, van der Werf S, Lebon P, Rapha\u00ebl JC, Gaillard JL, Gault E: Guillain-Barr\u00e9 syndrome and influenza virus infection. Clin Inf Dis. 2009, 48: 48-56. 10.1086\/594124.","journal-title":"Clin Inf Dis"},{"key":"3096_CR9","doi-asserted-by":"publisher","first-page":"1797","DOI":"10.1056\/NEJM199812173392501","volume":"339","author":"T Lasky","year":"1998","unstructured":"Lasky T, Terracciano GJ, Magder L, Koski CL, Ballesteros M, Nash D, Clark S, Haber P, Stolley PD, Schonberger LB, Chen RT: The Guillain-Barr\u00e9 syndrome and the 1992-1993 and 1993-1994 influenza vaccines. N Engl J Med. 1998, 339: 1797-1802. 10.1056\/NEJM199812173392501.","journal-title":"N Engl J Med"},{"key":"3096_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/aje\/kwn310","volume":"169","author":"J Stowe","year":"2009","unstructured":"Stowe J, Andrews N, Wise L, Miller E: Investigation of the temporal association of Guillain-Barr\u00e9 syndrome with influenza vaccine and influenza-like illness using the United Kingdom General Practice Research Database. Am J Epidemiol. 2009, 169: 382-388.","journal-title":"Am J Epidemiol"},{"key":"3096_CR11","doi-asserted-by":"publisher","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","volume":"374","author":"S Black","year":"2009","unstructured":"Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C: Importance of background rates of disease in assessment of vaccine safety during mass immunization with pandemic H1N1 influenza vaccines. Lancet. 2009, 374: 2115-2122.","journal-title":"Lancet"},{"key":"3096_CR12","unstructured":"Statistics Canada: Estimates of population, by age group and sex for July 1, Canada, provinces and territories, annual. CANSIM Table 051-0001"},{"key":"3096_CR13","unstructured":"Public Health Agency of Canada: Distribution of the H1N1 vaccine. [\n                    http:\/\/origin.phac-aspc.gc.ca\/alert-alerte\/h1n1\/vacc\/dist-eng.php\n                    \n                  ]"},{"key":"3096_CR14","unstructured":"Ontario Ministry of Health and Long-Term Care Fact Sheet: You Call the Shot: H1N1 Public Education Campaign. [\n                    http:\/\/www.health.gov.on.ca\/en\/news\/release\/2009\/dec\/fact_20091218.aspx\n                    \n                  ]"},{"key":"3096_CR15","unstructured":"The H1N1 Pandemic - How Ontario Fared: A Report by Ontario's Chief Medical Officer of Health. [\n                    http:\/\/www.health.gov.on.ca\/en\/public\/publications\/ministry_reports\/cmoh_h1n1\/cmoh_h1n1_20100602.pdf\n                    \n                  ]"},{"key":"3096_CR16","unstructured":"Foisy J, Rosella LC, Sanderson R, Hamid JS, Dhar B, Crowcroft NS: Self reported influenza A (H1N1) 2009 monovalent vaccination coverage for Ontario, Canada. Health Reports."},{"key":"3096_CR17","unstructured":"Gilmour H, Hofmann N: H1N1 vaccination. Health Reports. 21: 1-7."},{"key":"3096_CR18","first-page":"50","volume-title":"European Scientific Conference on Applied Infectious Disease Epidemiology Abstract Book. Lisbon","author":"C Achonu","year":"2010","unstructured":"Achonu C, LaFreniere M, Gubbay J, Rosella L, Deeks S, Mazzulli T, Rebbapragada A, Johnson I, Willison D, Johnson C, Chiodo A, Shi L, Willmore J, Yue C, Tom J, Crowcroft N: A seroprevalence study of pandemic influenza A H1N1 among Ontarians. European Scientific Conference on Applied Infectious Disease Epidemiology Abstract Book. Lisbon. 2010, 50-"},{"key":"3096_CR19","volume-title":"Vaccine Surveillance Report - Adverse Events following Immunization","author":"Public Health Agency of Canada","year":"2010","unstructured":"Public Health Agency of Canada: Vaccine Surveillance Report - Adverse Events following Immunization. 2010, [\n                    http:\/\/www.phac-aspc.gc.ca\/alert-alerte\/h1n1\/vacc\/addeve-eng.php\n                    \n                  ]"},{"key":"3096_CR20","volume-title":"Final summary of adverse drug reaction reports in Sweden with Pandemrix through October 2009 - mid April 2010","author":"L\u00e4kemedelverket Medical Products Agency","year":"2010","unstructured":"L\u00e4kemedelverket Medical Products Agency: Final summary of adverse drug reaction reports in Sweden with Pandemrix through October 2009 - mid April 2010. 2010, [\n                    http:\/\/www.lakemedelsverket.se\/upload\/eng-mpa-se\/Pandemrix%20ADRs%20in%20Sweden%2015%20april%202010.pdf\n                    \n                  ]"},{"key":"3096_CR21","unstructured":"Medicines and Healthcare Products Regulatory Agency: Final Public Summary: UK Suspected Adverse Reaction Analysis Swine Flu (H1N1) Vaccines - Celvapan and Pandemrix - March 26, 2010. [\n                    http:\/\/www.mhra.gov.uk\/home\/groups\/pl-p\/documents\/websiteresources\/con078911.pdf\n                    \n                  ]"},{"key":"3096_CR22","doi-asserted-by":"publisher","first-page":"7248","DOI":"10.1016\/j.vaccine.2010.09.021","volume":"28","author":"C Vellozzi","year":"2010","unstructured":"Vellozzi C, Broder KR, Haber P, Guh A, Nguyen M, Cano M, Lewis P, McNeil MM, Bryant M, Singleton J, Martin D, DeStefano F: Adverse events following influenza A (H1N1) 2009 monovalent vaccines reported to the Vaccine Adverse Event Reporting System, United States, October 1, 2009-January 31, 2010. Vaccine. 2010, 28: 7248-7255. 10.1016\/j.vaccine.2010.09.021.","journal-title":"Vaccine"},{"key":"3096_CR23","first-page":"657","volume":"59","author":"CDC","year":"2010","unstructured":"CDC: Preliminary results: Surveillance for Guillain-Barr\u00e9 syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine -- United States, 2009-2010. MMWR. 2010, 59: 657-661.","journal-title":"MMWR"},{"key":"3096_CR24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/S1473-3099(10)70140-7","volume":"10","author":"HC Lehmann","year":"2010","unstructured":"Lehmann HC, Hartung HP, Kieseier BC, Hughes RAC: Guillain-Barr\u00e9 syndrome after exposure to influenza virus. Lancet Infect Dis. 2010, 10: 643-651. 10.1016\/S1473-3099(10)70140-7.","journal-title":"Lancet Infect Dis"},{"key":"3096_CR25","volume-title":"Reported by Joanna Frketich","author":"The Hamilton Spectator","year":"2009","unstructured":"The Hamilton Spectator: Resident gets Guillain-Barr\u00e9 after H1N1 shot. Reported by Joanna Frketich. 2009"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2458-11-329\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-329","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2458-11-329.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,21]],"date-time":"2019-01-21T20:40:46Z","timestamp":1548103246000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/1471-2458-11-329"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,17]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["3096"],"URL":"https:\/\/doi.org\/10.1186\/1471-2458-11-329","relation":{},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,17]]},"article-number":"329"}}